While our study warrants further drug screening for more potent and specific FOXM1 inhibitors39, it is also of great interest that the FOXM1 upstream regulatory kinase MELK is also highly expressed, suggesting that this could act as a good candidate drug target for ultra-high risk neuroblastoma patients. Here, MELK is linked to neuroblastoma.